Analytical Data
-
基因名
PSMD9
- Application
-
别名
PSMD9;26S proteasome non-ATPase regulatory subunit 9
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O00233
-
表达区间
1-223aa
-
氨基酸序列
MGSSHHHHHHSSGLVPRGSHMGSMSDEEARQSGGSSQAGVVTVSDVQELM RRKEEIEAQIKANYDVLESQKGIGMNEPLVDCEGYPRSDVDLYQVRTARH NIICLQNDHKAVMKQVEEALHQLHARDKEKQARDMAEAHKEAMSRKLGQS ESQGPPRAFAKVNSISPGSPASIAGLQVDDEIVEFGSVNTQNFQSLHNIG SVVQHSEGKPLNVTVIRRGEKHQLRLVPTRWAGKGLLGCNIIPLQR
-
分子量
27 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PSMD9 (Proteasome 26S subunit, non-ATPase 9) plays a pivotal role in the function of the 26S proteasome, a critical complex responsible for the degradation of ubiquitinated proteins in eukaryotic cells. This process is essential for maintaining cellular homeostasis, regulating various physiological processes, and removing damaged or misfolded proteins that could otherwise lead to neurodegenerative disorders and cancer. Research into PSMD9 has garnered significant attention due to its involvement in regulating cellular responses to stress, apoptosis, and immune responses. Recent studies have indicated that PSMD9 can influence the stability and activity of several substrates involved in key signaling pathways, further underscoring its potential as a therapeutic target. The recombinant production of PSMD9 allows researchers to investigate its structure, function, and role in proteasome activity, paving the way for potential interventions in diseases where proteasome dysfunction is implicated. Understanding PSMD9's functionality at the molecular level could lead to novel strategies for the treatment of various conditions, including malignancies, where the proteasome's role is often corrupted. Consequently, the study of PSMD9 not only enhances our comprehension of proteasomal mechanisms but also highlights its significance in developing new therapeutic approaches targeting proteasome-related pathways. As research continues, elucidating the intricate relationships between PSMD9 and cellular processes may offer insights into innovative treatments for diseases characterized by proteostasis imbalances.












